pre-miRNA Information
pre-miRNA hsa-mir-125b-2   
Genomic Coordinates chr21: 16590237 - 16590325
Synonyms MIRN125B2, MIR125B2
Description Homo sapiens miR-125b-2 stem-loop
Comment This miRNA sequence is predicted based on homology to a verified miRNA from mouse .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-125b-2-3p
Sequence 54| UCACAAGUCAGGCUCUUGGGAC |75
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 3 21 + 16590292 29233923 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs575583557 6 dbSNP
rs1331783293 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol SYTL4   
Synonyms SLP4
Description synaptotagmin like 4
Transcript NM_001129896   
Other Transcripts NM_001174068 , NM_080737   
Expression
Putative miRNA Targets on SYTL4
3'UTR of SYTL4
(miRNA target sites are highlighted)
>SYTL4|NM_001129896|3'UTR
   1 GTCCCTGTCCTCTTCTGCAGGTCCAGCCCTGGCGAGGGCAGGTCAGAGGAAGTGAAGAAATCAAGAGCAAAGATTTATAA
  81 TTTAATGTGTATGTGTGTATGTGTGTATGTGTGTGTGTGTGTGTGTGTGTGTATGTGTACAAACATGTATTTTCTGCAAA
 161 TCTCATTATGCTGGCTAGAGTGATGCAGACTTGTTCTTCTTTTTAAAGCAGTCTCAAGAATAAGCATTTCTTTAAAATGT
 241 TTCTGTGTATAATCTAGTTTATTTTCAGAGTCCATTTTTTCTTATGTCTTTATAAGGTTCACTTAACTTAAAAACAGCTT
 321 TTAAAACAACTTTTTATCTTCTGTCTTGCTATCATTGTTCCTACTTCCCTAGGAAGCCCTGGCTACCTTTCGCATTAGGA
 401 CCAGTCTGGGTTTTAAGGCTCTGGGAAGCAGGGTTGGTTAGTAAAGACAGGAATGTTGGGGAGAGGTGAGTAGTTCCTTC
 481 CTCTTTCTCCTCTCCAATTTATGCTTTTAACTTATTTTCTACCTGGATAAACTTCTGGAACTTGGCTTTTAAATTTAACT
 561 TTTCTAGTTTTTAAGCAGTTTCCACCTTGCTTTGGTCTAATGCTTTTCTTTGAAATGCTAACAGAATTCCCAAGCTTTTT
 641 CCAGTTCTAGATATCTTTACTAGACCTTTGGGGGACTCTTATAATGGAGCTGCTTTTGAAAAGCACTTTAATTAGATAAT
 721 GTATTTTGACTAAATCACGAGGATGCCCAGTGAGAGCTTCTAGCTGATCTCAGAGGACCAGAGTGACTGAGGGTAAAGTG
 801 TCTCACAGCCCATGCTGAATTTTCTGCATTTTAAACTGATACTGCAGTCATTGGAGAGAGAGCTCCTCATTTCTCGAATG
 881 AAAGATGAGATATATTCATCCTCATGTACCACATCTGTCTTAGTGTTTGCGTCTGGGGTGTGTTATCAAACAGAGCATGG
 961 TCTACATCCCACTGTGTCAACCAGAAGAGCCAAGTGTTATCTCAATTGGCCCAGTGTTTCTCCAGGCTGGGGACTGTTAA
1041 GGGCTCTAAGGGAATGTAGACAGAGTCTCCCTGTTATTCTGACTTCCTGCTTGATGAGCTTTCAGTTCCTGTTTTTGCTA
1121 TTGTTTCCTAAATTTGACCTACATATTACATGGGTGTAGTGTGTTGAGGCTTTTCAAAGAAGGGTCTAGTGAGCTAAGTT
1201 TCATCTTCTGGTACTCATTGATCAAACTGACCTTTCTATTCTCATAAGCGTTTCTACCCAAAGTTGTGTGTGGAAGGAGT
1281 GTATAGCAGAGAGGAAATCCCTTTCAACAGAGTCAGCTGCTAACTGATTTCCTATAAGCACACTGGATTAAGGGCAGCCA
1361 CAGTGGTTTCTACTGTATGTATGAACCGAATGGAGGAATGTTTTCAAAGATTGATTTGGTGTGGATTGCAATTGTAATGG
1441 AAGGCATAACTTGGGATCCCGGGCTGTAACTTGCTCTTTTGTTTCCCACCCCCCTGACATGTATGTGTGCTTTAATAAAG
1521 CTTTCTCACTTGTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' caggGUUCUCG----GACUGAACAcu 5'
              | ||||:    | |||||||  
Target 5' ctggCTAGAGTGATGCAGACTTGTtc 3'
171 - 196 136.00 -9.90
2
miRNA  3' caggGUUCUCG---GACUGAACAcu 5'
              :|| |||   || ||||||  
Target 5' ttaaTAA-AGCTTTCTCACTTGTca 3'
1512 - 1535 133.00 -6.90
3
miRNA  3' cagggUUCUCGGACUGAACACu 5'
               ||| || | ||||| | 
Target 5' aatggAAG-GCATAACTTGGGa 3'
1436 - 1456 124.00 -8.50
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs8780 1493 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs754334762 1 dbSNP
rs1158334183 3 dbSNP
rs1396068936 7 dbSNP
rs766996024 26 dbSNP
rs1049930392 29 dbSNP
rs1182373295 32 dbSNP
rs200526563 33 dbSNP
rs186949124 34 dbSNP
rs1205556285 38 dbSNP
rs767752854 41 dbSNP
rs765447537 42 dbSNP
rs1264317460 46 dbSNP
rs762011855 51 dbSNP
rs781443908 54 dbSNP
rs111678811 66 dbSNP
rs988109782 72 dbSNP
rs868529234 99 dbSNP
rs867713233 105 dbSNP
rs201385766 107 dbSNP
rs1275192337 109 dbSNP
rs1436222003 110 dbSNP
rs1421664793 111 dbSNP
rs747241183 113 dbSNP
rs1192101464 115 dbSNP
rs1476018865 115 dbSNP
rs199736998 115 dbSNP
rs777259322 115 dbSNP
rs1488290483 117 dbSNP
rs1394972684 118 dbSNP
rs1463551286 123 dbSNP
rs1330115393 131 dbSNP
rs1491229255 132 dbSNP
rs1491291837 133 dbSNP
rs1491453352 133 dbSNP
rs4828041 133 dbSNP
rs55934817 133 dbSNP
rs67841104 134 dbSNP
rs1491418814 135 dbSNP
rs60877328 135 dbSNP
rs747727989 137 dbSNP
rs10623103 139 dbSNP
rs1195797901 139 dbSNP
rs1267098694 139 dbSNP
rs1429416959 139 dbSNP
rs868135029 139 dbSNP
rs750128469 140 dbSNP
rs772500425 140 dbSNP
rs867772362 140 dbSNP
rs778906164 147 dbSNP
rs1022779689 157 dbSNP
rs1297174053 168 dbSNP
rs1013398038 184 dbSNP
rs1216218531 186 dbSNP
rs1339812914 196 dbSNP
rs757189558 202 dbSNP
rs753767538 204 dbSNP
rs1265023563 215 dbSNP
rs1416422993 217 dbSNP
rs1486326984 226 dbSNP
rs1399707025 231 dbSNP
rs1260131587 233 dbSNP
rs1488235643 238 dbSNP
rs1189346766 263 dbSNP
rs763845887 270 dbSNP
rs952200357 274 dbSNP
rs796241020 286 dbSNP
rs1462737180 300 dbSNP
rs760488435 302 dbSNP
rs1168675008 307 dbSNP
rs1477525375 310 dbSNP
rs1454021818 312 dbSNP
rs1419242137 327 dbSNP
rs986655411 332 dbSNP
rs1358443770 338 dbSNP
rs993520169 343 dbSNP
rs1313339181 348 dbSNP
rs1190650601 351 dbSNP
rs1422439761 353 dbSNP
rs898040015 361 dbSNP
rs370671348 391 dbSNP
rs7063127 392 dbSNP
rs1241504682 400 dbSNP
rs1284303992 404 dbSNP
rs1353526880 405 dbSNP
rs1212053635 437 dbSNP
rs889270170 443 dbSNP
rs1050656235 445 dbSNP
rs754066518 450 dbSNP
rs767268332 456 dbSNP
rs914336509 457 dbSNP
rs759211133 460 dbSNP
rs1259562682 466 dbSNP
rs934348560 483 dbSNP
rs1316702829 485 dbSNP
rs1419282934 490 dbSNP
rs924504623 494 dbSNP
rs1006137743 495 dbSNP
rs1418801595 506 dbSNP
rs774004760 510 dbSNP
rs1246824018 514 dbSNP
rs1338610064 518 dbSNP
rs1464514217 519 dbSNP
rs41310707 543 dbSNP
rs762246741 576 dbSNP
rs1393359843 585 dbSNP
rs1307271359 590 dbSNP
rs1376460773 593 dbSNP
rs1235425579 594 dbSNP
rs971309841 613 dbSNP
rs915725251 616 dbSNP
rs1034002190 622 dbSNP
rs191190551 629 dbSNP
rs1199997583 657 dbSNP
rs1438728945 674 dbSNP
rs1329508278 681 dbSNP
rs1193989116 683 dbSNP
rs1465199329 691 dbSNP
rs1396708287 695 dbSNP
rs1431353260 699 dbSNP
rs760950494 738 dbSNP
rs768937564 739 dbSNP
rs747391721 740 dbSNP
rs1463541968 742 dbSNP
rs1329424813 747 dbSNP
rs952192357 764 dbSNP
rs1441968988 775 dbSNP
rs1306055677 776 dbSNP
rs1456894507 780 dbSNP
rs1219156066 785 dbSNP
rs780311378 791 dbSNP
rs1027740659 795 dbSNP
rs972450301 804 dbSNP
rs1296847624 807 dbSNP
rs962051532 821 dbSNP
rs772295113 824 dbSNP
rs1199938808 841 dbSNP
rs138601724 843 dbSNP
rs1457020519 845 dbSNP
rs1213991953 857 dbSNP
rs1248233982 861 dbSNP
rs906927248 875 dbSNP
rs889405835 876 dbSNP
rs1420086941 880 dbSNP
rs1421199086 891 dbSNP
rs1168584633 892 dbSNP
rs1029542699 894 dbSNP
rs1462152517 906 dbSNP
rs778994011 909 dbSNP
rs1348369912 930 dbSNP
rs757339687 931 dbSNP
rs1176324996 938 dbSNP
rs1011078742 939 dbSNP
rs186394828 940 dbSNP
rs1273329155 944 dbSNP
rs1316828991 958 dbSNP
rs1233366402 992 dbSNP
rs1291513778 995 dbSNP
rs1054226731 996 dbSNP
rs1220509681 999 dbSNP
rs1242534534 1000 dbSNP
rs1211102028 1005 dbSNP
rs1354209213 1010 dbSNP
rs934442116 1033 dbSNP
rs1489217831 1047 dbSNP
rs1191494034 1049 dbSNP
rs1262564382 1057 dbSNP
rs1475538971 1059 dbSNP
rs902836096 1073 dbSNP
rs1045411267 1077 dbSNP
rs1405030088 1093 dbSNP
rs949961742 1094 dbSNP
rs1239534276 1096 dbSNP
rs1160255338 1098 dbSNP
rs1378790840 1109 dbSNP
rs1347371669 1127 dbSNP
rs1398686905 1143 dbSNP
rs915837585 1149 dbSNP
rs1307358339 1165 dbSNP
rs1356676686 1180 dbSNP
rs1414817782 1184 dbSNP
rs1285483586 1201 dbSNP
rs1353787101 1205 dbSNP
rs183497469 1220 dbSNP
rs1284679423 1227 dbSNP
rs1355673358 1230 dbSNP
rs1371985183 1236 dbSNP
rs1214184794 1244 dbSNP
rs1052675845 1249 dbSNP
rs936918158 1250 dbSNP
rs991691291 1259 dbSNP
rs775864729 1260 dbSNP
rs1235855179 1270 dbSNP
rs755921711 1294 dbSNP
rs1390672366 1297 dbSNP
rs1472582098 1310 dbSNP
rs1178059497 1321 dbSNP
rs920646808 1326 dbSNP
rs972129423 1334 dbSNP
rs986132688 1341 dbSNP
rs1455678580 1342 dbSNP
rs1376556766 1343 dbSNP
rs932079967 1356 dbSNP
rs1378791952 1364 dbSNP
rs1335600069 1367 dbSNP
rs752553478 1378 dbSNP
rs1438763312 1382 dbSNP
rs190632064 1387 dbSNP
rs185769832 1388 dbSNP
rs976321167 1420 dbSNP
rs1237640266 1440 dbSNP
rs1308311194 1442 dbSNP
rs1348475516 1443 dbSNP
rs1202159389 1450 dbSNP
rs987478213 1460 dbSNP
rs953719639 1482 dbSNP
rs8780 1493 dbSNP
rs1205581354 1494 dbSNP
rs1178379593 1496 dbSNP
rs1355602309 1496 dbSNP
rs1011465222 1500 dbSNP
rs777068334 1529 dbSNP
rs140612294 1538 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293S
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... HITS-CLIP data was present in GSM1084064. RNA binding protein: AGO2. Condition:CLIP_noemetine_AbnovaAb ...

- Karginov FV; Hannon GJ, 2013, Genes & development.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' caggguuCUCGGACUGA-ACACu 5'
                 |||  ||| | |||| 
Target 5' -------GAG--UGAGUGUGUGu 3'
1 - 14
Article - Karginov FV; Hannon GJ
- Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
CLIP-seq Support 1 for dataset GSM1084064
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293S / CLIP_noemetine_AbnovaAb
Location of target site ENST00000372989.1 | 3UTR | GAGUGAGUGUGUGUGU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23824327 / GSE44404
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE42095 Differentiated embryonic stem cells 0.741 2.6e-5 0.774 7.3e-6 23 Click to see details
GSE28544 Breast cancer 0.606 8.5e-4 0.665 2.0e-4 24 Click to see details
GSE19536 Breast cancer -0.259 4.6e-3 -0.208 1.9e-2 100 Click to see details
GSE21032 Prostate cancer 0.21 2.8e-2 0.149 8.9e-2 83 Click to see details
GSE19783 ER- ER- breast cancer -0.195 4.3e-2 -0.172 6.5e-2 79 Click to see details
GSE15076 Monocyte-derived dendritic cells 0.991 4.3e-2 1.000 5.0e-1 3 Click to see details
GSE38226 Liver fibrosis -0.37 4.9e-2 -0.337 6.8e-2 21 Click to see details
GSE19783 ER+ ER+ breast cancer -0.358 6.1e-2 -0.200 2.0e-1 20 Click to see details
GSE28260 Renal cortex and medulla 0.412 8.1e-2 0.445 6.4e-2 13 Click to see details
GSE38974 Chronic obstructive pulmonary disease -0.237 1.3e-1 -0.201 1.7e-1 25 Click to see details
GSE21687 Ependynoma primary tumors -0.121 1.7e-1 -0.089 2.4e-1 64 Click to see details
GSE35602 Colorectal cancer stromal tissue -0.186 1.9e-1 0.034 4.4e-1 25 Click to see details
GSE32688 Pancreatic cancer 0.14 2.2e-1 0.273 6.5e-2 32 Click to see details
GSE19350 CNS germ cell tumors -0.189 2.8e-1 -0.219 2.5e-1 12 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis -0.134 2.9e-1 0.063 4.0e-1 20 Click to see details
GSE26953 Aortic valvular endothelial cells 0.054 4.0e-1 0.057 4.0e-1 24 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
PRAD 0.4 0 0.388 0 50 Click to see details
LIHC 0.305 0.02 0.245 0.04 49 Click to see details
KIRP -0.284 0.06 -0.216 0.12 32 Click to see details
THCA 0.185 0.08 0.172 0.1 59 Click to see details
KIRC 0.168 0.09 0.163 0.09 68 Click to see details
UCEC -0.323 0.09 -0.093 0.35 19 Click to see details
CHOL 0.468 0.1 0.300 0.22 9 Click to see details
CESC -0.923 0.13 -1.000 0.5 3 Click to see details
PAAD 0.742 0.13 0.800 0.1 4 Click to see details
LUAD -0.297 0.17 0.175 0.29 12 Click to see details
ESCA -0.296 0.19 -0.318 0.17 11 Click to see details
KICH 0.141 0.25 -0.018 0.47 25 Click to see details
HNSC 0.075 0.32 0.081 0.31 42 Click to see details
PCPG 0.295 0.4 0.500 0.33 3 Click to see details
LUSC -0.037 0.41 -0.120 0.24 38 Click to see details
BLCA 0.05 0.42 0.234 0.18 18 Click to see details
STAD -0.031 0.43 -0.172 0.17 32 Click to see details
BRCA 0.015 0.45 0.051 0.32 84 Click to see details
COAD -0.043 0.46 -0.024 0.48 8 Click to see details
COAD -0.043 0.46 -0.024 0.48 8 Click to see details
COAD -0.043 0.46 -0.024 0.48 8 Click to see details
91 hsa-miR-125b-2-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT038624 HN1L Jupiter microtubule associated homolog 2 1 1
MIRT038625 KDELC2 KDEL motif containing 2 1 1
MIRT038626 ABHD15 abhydrolase domain containing 15 1 1
MIRT038627 PPP1R12C protein phosphatase 1 regulatory subunit 12C 1 1
MIRT038628 MSANTD4 Myb/SANT DNA binding domain containing 4 with coiled-coils 1 1
MIRT038629 ASH2L ASH2 like histone lysine methyltransferase complex subunit 1 1
MIRT038630 USP22 ubiquitin specific peptidase 22 1 1
MIRT038631 CSTB cystatin B 1 1
MIRT038632 SYT2 synaptotagmin 2 1 1
MIRT038633 NDUFS7 NADH:ubiquinone oxidoreductase core subunit S7 1 1
MIRT038634 MTA2 metastasis associated 1 family member 2 1 1
MIRT053086 IGF1R insulin like growth factor 1 receptor 3 1
MIRT055788 PLEKHA1 pleckstrin homology domain containing A1 2 12
MIRT061248 AMOTL1 angiomotin like 1 2 10
MIRT061649 BTG2 BTG anti-proliferation factor 2 2 6
MIRT079046 TNRC6C trinucleotide repeat containing 6C 2 4
MIRT084583 BCL2L11 BCL2 like 11 2 8
MIRT093523 GALNT7 polypeptide N-acetylgalactosaminyltransferase 7 2 2
MIRT097383 LHFPL2 LHFPL tetraspan subfamily member 2 2 4
MIRT098030 SOBP sine oculis binding protein homolog 2 2
MIRT186262 TCEB3 elongin A 2 2
MIRT187284 DAZAP2 DAZ associated protein 2 2 10
MIRT361113 LRRC1 leucine rich repeat containing 1 2 2
MIRT443585 FAM84B family with sequence similarity 84 member B 2 2
MIRT452249 TRAM1 translocation associated membrane protein 1 2 2
MIRT476289 GMFB glia maturation factor beta 2 8
MIRT483871 MRPL12 mitochondrial ribosomal protein L12 2 2
MIRT484250 ANK1 ankyrin 1 2 2
MIRT499251 VAV3 vav guanine nucleotide exchange factor 3 2 4
MIRT502270 HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 2 4
MIRT504652 RPL9 ribosomal protein L9 2 6
MIRT505210 UBN2 ubinuclein 2 2 6
MIRT512690 POP1 POP1 homolog, ribonuclease P/MRP subunit 2 2
MIRT517341 ZNF529 zinc finger protein 529 2 4
MIRT518946 LSG1 large 60S subunit nuclear export GTPase 1 2 2
MIRT520866 SUGT1 SGT1 homolog, MIS12 kinetochore complex assembly cochaperone 2 2
MIRT521236 SAR1A secretion associated Ras related GTPase 1A 2 2
MIRT528324 GIGYF2 GRB10 interacting GYF protein 2 2 2
MIRT533297 USP46 ubiquitin specific peptidase 46 2 2
MIRT541024 WEE1 WEE1 G2 checkpoint kinase 2 4
MIRT544034 ERRFI1 ERBB receptor feedback inhibitor 1 2 2
MIRT547037 POGZ pogo transposable element derived with ZNF domain 2 2
MIRT556102 MOAP1 modulator of apoptosis 1 2 2
MIRT558320 DR1 down-regulator of transcription 1 2 2
MIRT558520 CSRNP3 cysteine and serine rich nuclear protein 3 2 2
MIRT566230 PTMA prothymosin, alpha 2 4
MIRT568437 ARPP19 cAMP regulated phosphoprotein 19 2 2
MIRT570584 OTUD7B OTU deubiquitinase 7B 2 2
MIRT571384 JKAMP JNK1/MAPK8-associated membrane protein 2 2
MIRT572798 SIGLEC14 sialic acid binding Ig like lectin 14 2 2
MIRT573864 C9orf78 chromosome 9 open reading frame 78 2 2
MIRT609930 SLC38A1 solute carrier family 38 member 1 2 4
MIRT610437 CSMD2 CUB and Sushi multiple domains 2 2 2
MIRT614407 MURC caveolae associated protein 4 2 2
MIRT618625 GREB1 growth regulation by estrogen in breast cancer 1 2 2
MIRT620605 SAP30 Sin3A associated protein 30 2 2
MIRT635313 FAM179A TOG array regulator of axonemal microtubules 2 2 2
MIRT635918 GLTSCR2 NOP53 ribosome biogenesis factor 2 2
MIRT638507 MAP3K9 mitogen-activated protein kinase kinase kinase 9 2 2
MIRT640597 TM9SF4 transmembrane 9 superfamily member 4 2 2
MIRT644066 IQCE IQ motif containing E 2 2
MIRT648287 TRAPPC2L trafficking protein particle complex 2 like 2 2
MIRT653089 SSR3 signal sequence receptor subunit 3 2 2
MIRT654651 PTAFR platelet activating factor receptor 2 2
MIRT658084 FOXR2 forkhead box R2 2 2
MIRT665306 ZBTB37 zinc finger and BTB domain containing 37 2 2
MIRT665974 SYTL4 synaptotagmin like 4 2 2
MIRT674905 RASSF9 Ras association domain family member 9 2 2
MIRT680085 THAP1 THAP domain containing 1 2 2
MIRT681487 DIP2A disco interacting protein 2 homolog A 2 2
MIRT691243 DFNB59 pejvakin 2 2
MIRT692361 AGTRAP angiotensin II receptor associated protein 2 2
MIRT693034 MB21D1 Mab-21 domain containing 1 2 2
MIRT694478 LRTOMT leucine rich transmembrane and O-methyltransferase domain containing 2 2
MIRT696069 ZNF264 zinc finger protein 264 2 2
MIRT696579 TTC21B tetratricopeptide repeat domain 21B 2 2
MIRT696759 MTFMT mitochondrial methionyl-tRNA formyltransferase 2 2
MIRT697306 ZNF652 zinc finger protein 652 2 2
MIRT698736 STX12 syntaxin 12 2 2
MIRT701055 PARP2 poly(ADP-ribose) polymerase 2 2 2
MIRT701197 OTUD3 OTU deubiquitinase 3 2 2
MIRT701334 NSD1 nuclear receptor binding SET domain protein 1 2 2
MIRT703617 FBXO45 F-box protein 45 2 2
MIRT708893 ZNF780A zinc finger protein 780A 2 2
MIRT711621 DGKH diacylglycerol kinase eta 2 2
MIRT713744 TMEM81 transmembrane protein 81 2 2
MIRT715060 TMTC1 transmembrane and tetratricopeptide repeat containing 1 2 2
MIRT719711 CD101 CD101 molecule 2 2
MIRT720293 DLGAP3 DLG associated protein 3 2 2
MIRT722605 CCDC152 coiled-coil domain containing 152 2 2
MIRT724565 ACSBG1 acyl-CoA synthetase bubblegum family member 1 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-125b-2 Ascorbate approved 54670067 Microarray Metastatic melanoma cell lines 25202679 2014 up-regualted
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-125b-2 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-125b-2 Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-mir-125b-2 Imatinib 5291 NSC743414 approved resistant High Chronic Myelogenous Leukemia tissue
hsa-mir-125b-2 Doxorubicin 31703 NSC123127 approved sensitive Low Hepatocellular Carcinoma cell line (Huh-7, HLE, HuH1)
hsa-mir-125b-2 Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-mir-125b-2 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-125b-2 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-125b-2 Topotecan 60699 NSC609699 approved resistant cell line (W1)
hsa-mir-125b-2 Vincristine 5978 approved resistant cell line (W1)
hsa-mir-125b-2 Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-mir-125b-2 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-125b-2 Tamoxifen 2733525 NSC180973 approved sensitive cell line (MCF7)
hsa-mir-125b-2 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-125b-2-3p Platinum 23939 resistant High Ovarian Cancer tissue
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved sensitive Low Cervical Cancer tissue
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (SGC-7901)
hsa-miR-125b-2-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-125b-2-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-125b-2-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer tissue
hsa-miR-125b-2-3p Fluorouracil 3385 NSC19893 approved resistant High Gastric Cancer tissue
hsa-miR-125b-2-3p Cyclophosphamide + Doxorubicin + Vincristine + Prednisone + Rituximab resistant High Diffuse Large B-Cell Lymphoma cell line (SU-DHL-2)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (SGC-7901, BGC-823)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant High Lung Adenocarcinoma cell line (A549)
hsa-miR-125b-2-3p Oxaliplatin 6857599 NSC266046 approved sensitive Low Colorectal Cancer cell line (HCT8, HCT-116)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (A2780)
hsa-miR-125b-2-3p Antiepileptic Drug sensitive High Pediatric Epilepsy tissue
hsa-miR-125b-2-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-125b-2-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-miR-125b-2-3p 4-Hydroxytamoxifen+Tamoxifen resistant cell line (LY2)
hsa-miR-125b-2-3p Ethanol+Tamoxifen resistant cell line (LY2)
hsa-miR-125b-2-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-125b-2-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-125b-2-3p Oxaliplatin 6857599 NSC266046 approved resistant cell line (IGROV-1)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (IGROV-1)
hsa-miR-125b-2-3p Paclitaxel 36314 NSC125973 approved resistant cell line (PC3PR70)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-125b-2-3p Gemcitabine 60750 NSC613327 approved resistant cell line (PANC-1) (1500 ng/ml)
hsa-miR-125b-2-3p Gemcitabine 60750 NSC613327 approved resistant cell line (PANC-1) (100 ng/ml)
hsa-miR-125b-2-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (SGC-7901)
hsa-miR-125b-2-3p Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)

Error report submission